Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 846
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-38948014

RESUMO

Background: Musician's focal task-specific dystonia is a complex disorder of fine motor control, with incomplete understanding of its etiology. There have been relatively few trials of botulinum toxin in upper limb task-specific dystonia, and prior studies have yielded variable results, leading to skepticism regarding the utility of this approach in elite performers. Methods: We conducted a double-blind, placebo-controlled, randomized, cross-over study of incobotulinum toxin-A in 21 professional musicians with focal upper extremity task-specific dystonia affecting performance on their instrument, using a novel paradigm of initial injections followed by booster injections at two- and four-week intervals. The primary outcome measure was the change in blinded dystonia rating of the active arm by two expert raters using a Clinical Global Impression numeric scale at week 8 compared to enrollment. Findings: 19 men and 2 women with musicians' dystonia were enrolled over a six-year period. Nineteen patients completed the study. Analysis of the primary outcome measure in comparison to baseline revealed a change in dystonia severity of P = 0.04 and an improvement in overall musical performance of P = 0.027. No clinically significant weakness was observed, and neutralizing antibodies to toxin were not found. Interpretation: Despite its small sample size, our study demonstrated a statistically significant benefit of incobotulinum toxin-A injections as a treatment for musicians' task-specific dystonia. Tailoring the use of toxin with booster injections allowed refinement of dosing strategy and outcomes, with benefits that were meaningful to patients clearly visible on videotaped evaluations. In addition to its application to musicians' dystonia, this approach may have relevance to optimize application of botulinum toxin in other forms of focal dystonia such as blepharospasm, cervical dystonia, writer's cramp, and spasmodic dysphonia.


Assuntos
Toxinas Botulínicas Tipo A , Estudos Cross-Over , Distúrbios Distônicos , Música , Fármacos Neuromusculares , Humanos , Método Duplo-Cego , Masculino , Feminino , Toxinas Botulínicas Tipo A/administração & dosagem , Distúrbios Distônicos/tratamento farmacológico , Distúrbios Distônicos/fisiopatologia , Adulto , Fármacos Neuromusculares/administração & dosagem , Fármacos Neuromusculares/farmacologia , Pessoa de Meia-Idade , Resultado do Tratamento , Doenças Profissionais/tratamento farmacológico
2.
Occup Environ Med ; 81(5): 245-251, 2024 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-38782576

RESUMO

OBJECTIVES: The increase in gabapentinoid prescribing is paralleling the increase in serious harms. To describe the low back pain workers compensation population whose management included a gabapentinoid between 2010 and 2017, and determine secular trends in, and factors associated with gabapentinoid use. METHODS: We analysed claim-level and service-level data from the Victorian workers' compensation programme between 1 January 2010 and 31 December 2017 for workers with an accepted claim for a low back pain injury and who had programme-funded gabapentinoid dispensing. Secular trends were calculated as a proportion of gabapentinoid dispensings per year. Poisson, negative binomial and Cox hazards models were used to examine changes over time in incidence and time to first dispensing. RESULTS: Of the 17 689 low back pain claimants, one in seven (14.7%) were dispensed at least one gabapentinoid during the first 2 years (n=2608). The proportion of workers who were dispensed a gabapentinoid significantly increased over time (7.9% in 2010 to 18.7% in 2017), despite a reduction in the number of claimants dispensed pain-related medicines. Gabapentinoid dispensing was significantly associated with an opioid analgesic or anti-depressant dispensing claim, but not claimant-level characteristics. The time to first gabapentinoid dispensing significantly decreased over time from 311.9 days (SD 200.7) in 2010 to 148.2 days (SD 183.1) in 2017. CONCLUSIONS: The proportion of claimants dispensed a gabapentinoid more than doubled in the period 2010-2017; and the time to first dispensing halved during this period.


Assuntos
Analgésicos , Gabapentina , Dor Lombar , Indenização aos Trabalhadores , Humanos , Dor Lombar/tratamento farmacológico , Dor Lombar/epidemiologia , Feminino , Masculino , Adulto , Estudos Retrospectivos , Gabapentina/uso terapêutico , Pessoa de Meia-Idade , Indenização aos Trabalhadores/estatística & dados numéricos , Indenização aos Trabalhadores/tendências , Analgésicos/uso terapêutico , Vitória/epidemiologia , Doenças Profissionais/epidemiologia , Doenças Profissionais/tratamento farmacológico , Prescrições de Medicamentos/estatística & dados numéricos
3.
BMC Pharmacol Toxicol ; 22(1): 25, 2021 05 03.
Artigo em Inglês | MEDLINE | ID: mdl-33941274

RESUMO

BACKGROUND: There are no reports on the incidence of chronic mercury poisoning in a large population in China. This study investigated the epidemiology, clinical manifestations, treatment, and follow-up of Chinese patients with chronic mercury poisoning. METHODS: Data for 288 mercury poisoning patients were collected at our hospital from July 2014 to September 2019, including sex, age, admission time, blood mercury content, urine mercury content, creatinine, urinary mercury/creatinine ratio, 24-h urinary protein levels, electromyography (EMG) findings, renal biopsy, and follow-up. Patient characteristics were evaluated by statistical and correlation analyses. RESULTS: First, mercury poisoning in China mainly occurred through occupational exposure and the inappropriate use of mercury-containing cosmetics and Chinese folk remedies (CFRs). Second, the most common symptoms were nervous system (50.3 %), kidney (16.4 %) and breathing (8.0 %). Mercury poisoning-induced Nephrotic syndrome (NS) and peripheral neuropathy are common long-term complications. The complications of occupational and cosmetics-induced mercury poisoning are consistent with international belief. However, the NS caused by CFRs is mainly membranous nephropathy and the probability of peripheral neuropathy caused by CFRs is higher than other pathogens. Third, follow-up data shows that 13 patients with EMG-confirmed neurological injury, 10 showed full recovery after 38.50 ± 8.03 months. Furthermore, among 18 patients with NS, 15 had normal urine protein and serum albumin levels after 22.67 ± 10.26 months. CONCLUSIONS: Regulation of skin-lightening cosmetic products, safety surveillance of CFRs, and prevention and control of occupational exposure must be improved to decrease the incidence of mercury poisoning in China.


Assuntos
Intoxicação por Mercúrio , Doenças Profissionais , Adolescente , Adulto , Idoso , Anti-Inflamatórios/uso terapêutico , Quelantes/uso terapêutico , Criança , Pré-Escolar , China/epidemiologia , Doença Crônica , Cosméticos/toxicidade , Medicamentos de Ervas Chinesas/toxicidade , Feminino , Seguimentos , Humanos , Masculino , Mercúrio/sangue , Mercúrio/urina , Intoxicação por Mercúrio/sangue , Intoxicação por Mercúrio/tratamento farmacológico , Intoxicação por Mercúrio/epidemiologia , Intoxicação por Mercúrio/urina , Pessoa de Meia-Idade , Doenças Profissionais/sangue , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/epidemiologia , Doenças Profissionais/urina , Exposição Ocupacional/efeitos adversos , Prednisona/uso terapêutico , Estudos Retrospectivos , Unitiol/uso terapêutico , Adulto Jovem
4.
Skin Pharmacol Physiol ; 34(3): 135-145, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33789311

RESUMO

BACKGROUND: Oral supplementation with a standardized extract from the bark of the French pine (Pycnogenol®) has been reported to benefit the skin. It might thus represent an easy-to-use strategy to improve the skin health of individuals who are exposed to considerable environmental stress in large urban areas. OBJECTIVE: We investigated if oral intake of Pycnogenol® can benefit the skin of Han Chinese working outdoors in Beijing, China. METHODS: In a monocentre, double-blind, randomized, placebo-controlled, and crossover study, the effects of Pycnogenol® intake (2 × 50 mg/day for a total of 12 weeks) on a variety of skin physiological parameters was studied in Chinese subjects (n = 76), from spring to autumn, who were working outdoors in Beijing, China. RESULTS: During the intervention period, study subjects were constantly exposed to increased levels of particulate matter (PM)2.5 as well as seasonal changes in humidity and temperature. Despite this environmental stress, Pycnogenol® intake prevented (i) a decrease in the skin hydration, (ii) transepidermal water loss (TEWL), and (iii) skin darkening during the dry autumn season. In addition, Pycnogenol® intake improved (iv) viscoelastic skin properties such as gross elasticity and elastic recovery irrespective of the season. These beneficial effects were not observed if the same subjects were supplemented with placebo. CONCLUSION: Oral intake of Pycnogenol® benefits the skin in Han Chinese, who are working outdoors under considerable environmental stress.


Assuntos
Antioxidantes/farmacologia , Flavonoides/farmacologia , Extratos Vegetais/farmacologia , Pele/efeitos dos fármacos , China , Estudos Cross-Over , Método Duplo-Cego , Humanos , Doenças Profissionais/tratamento farmacológico , Material Particulado/análise , Estações do Ano , Pele/metabolismo , Água/metabolismo
5.
Am J Trop Med Hyg ; 104(5): 1639-1642, 2021 03 29.
Artigo em Inglês | MEDLINE | ID: mdl-33782212

RESUMO

Pararamosis is a medical condition, described in the latex extracting areas of the Amazon (rubber tree regions), resulting from contact with the caterpillar of the Premolis semirufa moth. The disease can present itself in an acute form-similarly to other erucisms (injuries caused by moth larvae in humans)-or in a chronic form, typically characterized by the occurrence of changes in the joints of the hands. Because of its importance, in the context of tropical diseases, the objective of this article was to review the main facets of the disease, emphasizing the different pathogenic aspects of the interaction between the arthropod and man.


Assuntos
Artrite/etiologia , Misturas Complexas/toxicidade , Eritema/etiologia , Larva/patogenicidade , Mariposas/patogenicidade , Doenças Profissionais/etiologia , Corticosteroides/uso terapêutico , Animais , Artrite/tratamento farmacológico , Artrite/patologia , Artrite/prevenção & controle , Brasil , Eritema/tratamento farmacológico , Eritema/patologia , Eritema/prevenção & controle , Mãos , Humanos , Articulações/efeitos dos fármacos , Articulações/patologia , Larva/química , Mariposas/química , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/patologia , Doenças Profissionais/prevenção & controle , Equipamento de Proteção Individual , Borracha/isolamento & purificação , Pele/efeitos dos fármacos , Pele/patologia
6.
Int J Occup Med Environ Health ; 34(1): 111-120, 2021 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-33300502

RESUMO

OBJECTIVES: Evaluating treatment outcomes of local corticosteroid injections for work-related lower back pain (LBP) as the current evidence for the American College of Occupational and Environmental Medicine guidelines is considered insufficient to recommend this practice. MATERIAL AND METHODS: The authors conducted a retrospective study involving the patients who were treated with peri-articular and lower lumbar corticosteroid injections for work-related LBP at their occupational medicine clinic. RESULTS: Sixty-four patients met the inclusion criteria. The average pain level was reduced from M±SD 5.1±2.0 to M±SD 3.1±2.3 after the corticosteroid injection (p < 0.0001). Thirty-five patients (55%) were discharged to regular duty; 23 (36%) were transferred to orthopedics due to persistent pain; and 6 (9%) were lost to follow-up. CONCLUSIONS: Corticosteroid injections for work-related LBP are effective in reducing pain and enhancing discharge to regular duty. Nonetheless, larger prospective trials are needed to validate these findings. Int J Occup Med Environ Health. 2021;34(1):111-20.


Assuntos
Corticosteroides/uso terapêutico , Dor Lombar/tratamento farmacológico , Entorses e Distensões/tratamento farmacológico , Corticosteroides/administração & dosagem , Adulto , Idoso , California , Feminino , Humanos , Injeções Intra-Articulares , Região Lombossacral/lesões , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/tratamento farmacológico , Estudos Retrospectivos , Retorno ao Trabalho/estatística & dados numéricos , Articulação Sacroilíaca , Resultado do Tratamento
7.
Int J Dermatol ; 60(1): 99-106, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33166092

RESUMO

BACKGROUND: Cutaneous sporotrichosis, a subcutaneous mycosis because of Sporothrix schenckii, is sporadic worldwide with local hyperendemic pockets. OBJECTIVES: To study clinico-epidemiological and therapeutic aspects of sporotrichosis in our clinic. METHODS: We retrospectively analyzed medical records of 152 (M:F 52:100) patients with cutaneous sporotrichosis managed during 2010-2019. RESULTS: All patients were involved in agricultural activities, and 63.2% were aged 21-60 years. Women outnumbered men by nearly two times. Fixed and lymphocutaneous sporotrichosis occurred in 54.6% and 43.4% patients, respectively. Only 2% of patients had multifocal sporotrichosis. Only 48% of patients imputed their disease to prior injuries. Extremities, upper in 53.9% and lower in 21% of patients, were mostly involved. Scrotum involvement in one patient was unusual. A mixed inflammatory infiltrate in 38.7%, chronic granuloma formation in 35%, and presence of spores in 48.9% biopsies was noted. S. schenckii grew on Sabouraud's dextrose agar in 40.2% of cases. Treatment with saturated solution of potassium iodide was curative in 76.8% patients, and lesions healed in 2-9 months (average 5.2 months). Metallic taste was experienced by 42.9% of patients. Itraconazole therapy was safe and effective in seven patients, and the response was better when combined with SSKI compared to either drug used alone. CONCLUSION: Cutaneous sporotrichosis mostly affects persons during active years of life. The injuries predisposing to infection are mostly forgotten. Both fixed and lymphocutaneous sporotrichosis involving extremities remain common forms. SSKI alone or in combination with itraconazole is safe and effective treatment. Itraconazole is preferable in patients having preexisting hypothyroidism or intolerance to SSKI.


Assuntos
Agricultura , Antifúngicos/uso terapêutico , Granuloma/microbiologia , Doenças Profissionais/tratamento farmacológico , Iodeto de Potássio/uso terapêutico , Esporotricose/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antifúngicos/efeitos adversos , Criança , Tratamento Farmacológico , Extremidades , Feminino , Humanos , Índia/epidemiologia , Itraconazol/uso terapêutico , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/epidemiologia , Doenças Profissionais/etiologia , Doenças Profissionais/patologia , Iodeto de Potássio/efeitos adversos , Estudos Retrospectivos , Esporos Fúngicos , Esporotricose/epidemiologia , Esporotricose/etiologia , Esporotricose/patologia , Ferimentos e Lesões/complicações , Adulto Jovem
8.
Am J Ind Med ; 64(1): 48-57, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33231876

RESUMO

BACKGROUND: Construction workers have high rates of work-related musculoskeletal disorders, which lead to frequent opioid use and opioid use disorder (OUD). This paper quantified the incidence of opioid use and OUD among construction workers with and without musculoskeletal disorders. METHODS: We conducted a retrospective study using union health claims from January 2015 to June 2018 from 19,909 construction workers. Claims for diagnoses of chronic musculoskeletal disorders, acute musculoskeletal injuries, musculoskeletal surgery, and other conditions were linked to new opioid prescriptions. We examined the effects of high doses (≥50 morphine mg equivalents per day), large supply (more than 7 days per fill), long-term opioid use (60 or more days supplied within a calendar quarter), and musculoskeletal disorders, on the odds of a future OUD. RESULTS: There were high rates (42.8% per year) of chronic musculoskeletal disorders among workers, of whom 24.1% received new opioid prescriptions and 6.3% received long-term opioid prescriptions per year. Workers receiving opioids for chronic musculoskeletal disorders had the highest odds of future OUD: 4.71 (95% confidence interval 3.09-7.37); workers prescribed long-term opioids in any calendar quarter had a nearly 10-fold odds of developing an OUD. CONCLUSIONS: Among construction workers, opioids initiated for musculoskeletal pain were strongly associated with incident long-term opioid use and OUD. Musculoskeletal pain from physically demanding work is likely one driver of the opioid epidemic in occupations like construction. Prevention of work injuries and alternative pain management are needed for workers at risk for musculoskeletal injuries.


Assuntos
Analgésicos Opioides/uso terapêutico , Indústria da Construção/estatística & dados numéricos , Dor Musculoesquelética/epidemiologia , Doenças Profissionais/epidemiologia , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Adulto , Doença Crônica , Prescrições de Medicamentos/estatística & dados numéricos , Humanos , Illinois/epidemiologia , Kansas/epidemiologia , Masculino , Pessoa de Meia-Idade , Missouri/epidemiologia , Dor Musculoesquelética/tratamento farmacológico , Dor Musculoesquelética/etiologia , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/etiologia , Razão de Chances , Transtornos Relacionados ao Uso de Opioides/etiologia , Estudos Retrospectivos
9.
Health Serv Res ; 56(1): 49-60, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33011988

RESUMO

OBJECTIVE: To test associations between several opioid prescribing policy interventions and changes in early (acute/subacute) high-risk opioid prescribing practices. DATA SOURCES: Population-based workers' compensation pharmacy billing and claims data, Washington State Department of Labor and Industries (January 2008-June 2015). STUDY DESIGN: We used interrupted time series analysis to test associations between three policy intervention timepoints and monthly proportions of population-based measures of high-risk, low-risk, and any workers' compensation-related opioid prescribing. We also tested associations between the policy intervention timepoints and five high-risk opioid prescribing indicators among workers prescribed any opioids within 3 months after injury: (a) >7 cumulative (not necessarily consecutive) days' supply of opioids during the acute phase, (b) high-dose opioids, (c) concurrent sedatives, (d) chronic opioids, and (e) a composite high-risk opioid prescribing indicator. PRINCIPAL FINDINGS: Within 3 months after injury, 9 percent of workers were exposed to high-risk and 12 percent to low-risk workers' compensation-related opioid prescribing; 79 percent filled no workers' compensation-related opioid prescription. Among workers prescribed any early (acute/subacute) opioids, the indicator for >7 days' supply of opioids during the acute phase was present for 30 percent, high-dose opioids for 18 percent, concurrent sedatives for 3 percent, and chronic opioids for 2 percent. Beyond a general shift toward more infrequent and lower-risk workers' compensation-related opioid prescribing, each policy intervention timepoint was significantly associated with reductions in specific acute/subacute high-risk opioid prescribing indicators; each of the four specific high-risk opioid prescribing indicators had significant reductions associated with at least one policy. CONCLUSIONS: Several state-level opioid prescribing policies were significantly associated with safer workers' compensation-related opioid prescribing practices during the first 3 months after injury (acute/subacute phase), which should in turn reduce transition to chronic opioids and associated negative health outcomes.


Assuntos
Analgésicos Opioides/uso terapêutico , Dor Crônica/tratamento farmacológico , Prescrições de Medicamentos/estatística & dados numéricos , Doenças Profissionais/tratamento farmacológico , Dor Crônica/epidemiologia , Humanos , Análise de Séries Temporais Interrompida , Doenças Profissionais/epidemiologia , Padrões de Prática Médica/estatística & dados numéricos , Resultado do Tratamento , Washington , Indenização aos Trabalhadores
10.
Infez Med ; 28(3): 351-356, 2020 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-32920570

RESUMO

The rapidly increased number of patients with COVID-19 resulted in the shortage of hospital beds. An outpatient follow-up plan was developed for COVID-19 patients with stable clinical condition and no concomitant diseases. The records of COVID-19 first admission clinic were retrospectively reviewed to identify the COVID-19 patients who were followed on home isolation as outpatients between March 17, 2020 and April 18, 2020 in Ankara, Turkey. Demographic and clinical characteristics of the patients, compliance with isolation rules, re-admission rates, and outcomes were investigated. A total of 41 patients with COVID-19 were followed on home isolation without hospitalization. The median age of the patients was 36 years. Twenty-four (58.5%) of 41 patients were female. Twenty-nine (70.7%) patients were healthcare workers. The most common symptoms at admission were cough, myalgia/arthralgia, and loss of smell and/or taste. Fourteen (34.1%) patients were asymptomatic on the first admission. Anti-viral treatment was given to 27 (65.8%) of 41 patients. Four of 41 patients were readmitted to the outpatient clinic and hospitalized. Three patients had worsening respiratory symptoms and pneumonia was detected in CT scans. One patient was hospitalized because of disseminated herpes zoster infection. Two patients who jeopardized the isolation rules were isolated and monitored at another hospital by provincial health directorate teams. If adequate conditions are provided, follow-up on home isolation seems to be a feasible method in carefully selected patients. However, these patients should be monitored closely by an experienced team during the isolation period.


Assuntos
Assistência Ambulatorial/métodos , Antivirais/uso terapêutico , Betacoronavirus , Infecções por Coronavirus/tratamento farmacológico , Isolamento de Pacientes/métodos , Pneumonia Viral/tratamento farmacológico , Adulto , Ocupação de Leitos , COVID-19 , Teste para COVID-19 , Técnicas de Laboratório Clínico/métodos , Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/transmissão , Feminino , Pessoal de Saúde/estatística & dados numéricos , Humanos , Masculino , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/epidemiologia , Pacientes Ambulatoriais , Pandemias , Pneumonia Viral/diagnóstico , Pneumonia Viral/epidemiologia , Pneumonia Viral/transmissão , Estudos Retrospectivos , SARS-CoV-2 , Avaliação de Sintomas , Turquia/epidemiologia
11.
Toxicol Ind Health ; 36(10): 800-806, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32812511

RESUMO

Because of the numerous industrial applications of lead (Pb), Pb poisoning is an important public health threat in the world particularly in developing and industrialized countries. Oxidative stress is one of the important mechanisms of Pb-mediated toxicity. Deferoxamine (DFO) is an iron chelating agent that has recently shown antioxidant and antiapoptotic effects. This study investigated the protective capacity of DFO against Pb-induced cardiotoxicity in rats. We used five groups in this study: control, DFO (300 mg/kg), Pb (50 mg/kg), DFO (150 mg/kg) + Pb, DFO (300 mg/kg) + Pb. DFO was administered intraperitoneally 30 min before intraperitoneal injection of Pb for 5 days. After drug treatment, the levels of lactate dehydrogenase (LDH), lipid peroxidation (LPO), glutathione (GSH), and antioxidant enzymes were measured in serum and heart samples. The results showed that pretreatment with DFO reduced Pb-induced oxidative stress markers in serum and cardiac tissues. We found that LDH and LPO levels were significantly increased in Pb-treated rats and decreased with DFO pre-administration. Furthermore, the decreased activities of total antioxidant capacity, and GSH were observed after Pb treatment. However, DFO administration effectively prevented the Pb-induced alterations of these antioxidant enzymes activities. In conclusion, the results presented here indicate that DFO has protective effects in Pb-induced cardiotoxicity in rats, probably due to its antioxidant action and inhibition of oxidative stress.


Assuntos
Cardiotoxicidade/tratamento farmacológico , Desferroxamina/farmacologia , Desferroxamina/uso terapêutico , Quelantes de Ferro/farmacologia , Quelantes de Ferro/uso terapêutico , Chumbo/toxicidade , Doenças Profissionais/tratamento farmacológico , Adulto , Animais , Cardiotoxicidade/fisiopatologia , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Animais , Exposição Ocupacional/efeitos adversos , Estresse Oxidativo/efeitos dos fármacos , Ratos , Ratos Wistar
13.
Folia Med (Plovdiv) ; 62(2): 398-402, 2020 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-32666752

RESUMO

This study aimed to describe the first two microbiologically confirmed cases of cutaneous and soft tissue Mycobacterium marinum infection in Bulgaria. The isolation of the Nontuberculous Mycobacteria (NTM) strains and their species identification was performed at NRL TB, NCIPD using specific media and cultivation conditions, and PCR based Line Probe Assay (LPA) from the positive cultures. The two patients had closely related jobs to fishes and water reservoirs and both of them had a similar clinical manifestation of M. mari-num infection known as "swimming pool" or "fish tank" granuloma. The prolonged specific treatment with at least two-drug combina-tion of rifampicin plus ethambutol and some complications were a big challenge for clinicians as well as the patients.


Assuntos
Síndrome do Túnel Carpal/diagnóstico , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium marinum/isolamento & purificação , Infecções dos Tecidos Moles/diagnóstico , Adulto , Antituberculosos/uso terapêutico , Bulgária , Síndrome do Túnel Carpal/etiologia , Síndrome do Túnel Carpal/cirurgia , Técnicas de Cultura , DNA Bacteriano/análise , Diagnóstico Tardio , Etambutol/uso terapêutico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium marinum/genética , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/microbiologia , Rifampina/uso terapêutico , Infecções dos Tecidos Moles/complicações , Infecções dos Tecidos Moles/tratamento farmacológico , Infecções dos Tecidos Moles/microbiologia
14.
Rehabilitacion (Madr) ; 54(3): 211-214, 2020.
Artigo em Espanhol | MEDLINE | ID: mdl-32563618

RESUMO

Epicondylitis causes disability and tends to become chronic. Histologically, degenerative lesions are found in the common extensor tendon, which are visible on ultrasound or magnetic resonance imaging. Several conservative therapeutic measures are available, including corticosteroid infiltration by anatomical landmark. However, these measures sometimes fail, in which case patients are proposed for surgery. Ultrasound is a therapeutic tool that allows procedures on tendons to be performed without skin incisions. The technique of ultrasound-guided percutaneous tenotomy for the treatment of chronic epicondylitis was first reported in 2006. This procedure, demonstrated to date by surgeons and radiologists, attempts to transform a chronic degenerative process with failure to repair into an acute inflammatory process with self-regeneration. The aim of this study was to describe 5 cases of epicondylitis that failed to respond to routine therapeutic measures, in which we used ultrasound-guided percutaneous tenotomy with favourable results.


Assuntos
Entesopatia/cirurgia , Cotovelo de Tenista/cirurgia , Tenotomia/métodos , Ultrassonografia de Intervenção/métodos , Articulação do Punho/cirurgia , Corticosteroides/administração & dosagem , Corticosteroides/uso terapêutico , Adulto , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Terapia Combinada , Entesopatia/tratamento farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Agulhas , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/cirurgia , Duração da Cirurgia , Recuperação de Função Fisiológica , Cotovelo de Tenista/tratamento farmacológico , Tenotomia/instrumentação
15.
Tunis Med ; 98(3): 241-245, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32395818

RESUMO

BACKGROUND: Skin lesions caused by avian mite bites are uncommon and often misdiagnosed. They are usually caused by bites from avian mites that have infested domestic poultry or birds nesting in or near human habitation. We report three cases of human skin lesions from avian mites infesting pigeons. OBSERVATIONS: Three persons working in the same place developed similar skin pruritic papules simultaneously. The diagnosis remained unknown until Dermanyssus gallinae (chicken mite) was found on the computer's table of the three individuals workplace, situated near a window where pigeons used to live. Antihistaminic treatment was carried out with a skin disinfestation. In two cases, symptoms resolved after one week of treatment. In the third case, corticosteroids were needed. CONCLUSIONS: Avian mite bites skin lesions can remain unrecognized or misdiagnosed. Inquiry about contact with pigeons or poultry may be helpful in patients with nonspecific skin lesions.


Assuntos
Doenças das Aves/parasitologia , Mordeduras e Picadas/diagnóstico , Columbidae/parasitologia , Infestações por Ácaros/parasitologia , Zoonoses/diagnóstico , Corticosteroides/uso terapêutico , Adulto , Animais , Doenças das Aves/transmissão , Mordeduras e Picadas/tratamento farmacológico , Mordeduras e Picadas/parasitologia , Antagonistas dos Receptores Histamínicos/uso terapêutico , Humanos , Infestações por Ácaros/diagnóstico , Infestações por Ácaros/transmissão , Infestações por Ácaros/veterinária , Ácaros/fisiologia , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/parasitologia , Zoonoses/tratamento farmacológico , Zoonoses/parasitologia , Zoonoses/transmissão
16.
J Clin Hypertens (Greenwich) ; 22(6): 962-969, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32436644

RESUMO

Hypertension is a risk factor for cardiovascular disease, which is the leading cause of death in the United States. Taxi and for-hire vehicle (FHV) drivers, a largely male, immigrant and medically underserved population, are at increased risk of cardiovascular disease, in part due to the nature of their work. This study examined demographic and lifestyle predictors of hypertension diagnosis awareness, objectively measured blood pressure (hypertensive-range vs non-hypertensive-range readings), medication use, and hypertension control. A cross-sectional assessment was conducted with 983 male taxi/FHV drivers who attended health fairs in New York City from 2010 to 2017. Twenty-three percent self-reported a hypertension history and 46% had hypertensive-range BP readings. Approximately, half the drivers lacked health insurance (47%) and a usual care source (46%). Thirty percent did not self-report hypertension and had hypertensive-range BP readings. Medication use was reported by 69% of hypertension-aware drivers, and being older and having health care access (insurance, a usual care source, and seeing a doctor in the past year) was significantly associated with medication use. Hypertension-unaware drivers with hypertensive-range BP readings were less likely to have a usual care source. Over 60% of drivers who were hypertension-aware and on medication had hypertensive-range readings. There is a need for community-based and workplace driver and provider interventions to address BP awareness and management and to provide health care navigation for vulnerable populations such as taxi/FHV vehicle drivers.


Assuntos
Condução de Veículo , Hipertensão , Doenças Profissionais , Condução de Veículo/estatística & dados numéricos , Estudos Transversais , Humanos , Hipertensão/diagnóstico , Hipertensão/tratamento farmacológico , Hipertensão/epidemiologia , Masculino , Pessoa de Meia-Idade , Cidade de Nova Iorque/epidemiologia , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/epidemiologia , Fatores de Risco
17.
Allergol Immunopathol (Madr) ; 48(6): 640-645, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32460992

RESUMO

BACKGROUND: Beekeepers and their families are at an increased risk of life-threatening anaphylaxis due to recurrent bee-sting exposures. OBJECTIVE: The aim of this study is to evaluate the demographic features, previous history of anaphylaxis among beekeepers and their family members, and their knowledge about the symptoms and management of anaphylaxis. METHODS: A standardized questionnaire was administered to beekeepers during the 6th International Beekeeping and Pine Honey Congress held in 2018, in Mugla, Turkey. Additionally, food-service staff from restaurants were surveyed as an occupational control group about their knowledge about anaphylaxis. RESULTS: Sixty-nine beekeepers (82.6% male, mean age 48.4±12.0 years) and 52 restaurant staff (46.2% male, mean age 40.5±10.0 years) completed the questionnaire. Awareness of the terms 'anaphylaxis' and 'epinephrine auto-injector' among the beekeepers were 55.1% and 30.4% and among the restaurant staff were 23.1% and 3.8%, respectively. Of the beekeepers, 74% were able to identify the potential symptoms of anaphylaxis among the given choices; 2.9% and 5.8% reported anaphylaxis related to bee-stings in themselves and in their family members, respectively. None of the restaurant staff had experienced or encountered anaphylaxis before but 3.8% of their family members had anaphylaxis and those reactions were induced by drugs. CONCLUSION: It is essential that implementation of focused training programs about anaphylaxis symptoms and signs as well as practical instructions of when and how to use an epinephrine auto-injector will decrease preventable morbidities and mortalities due to bee-stings in this selected high-risk population of beekeepers and their family members, as well as other fieldworkers under risk.


Assuntos
Anafilaxia/diagnóstico , Venenos de Abelha/efeitos adversos , Conhecimentos, Atitudes e Prática em Saúde , Mordeduras e Picadas de Insetos/complicações , Doenças Profissionais/diagnóstico , Adulto , Anafilaxia/imunologia , Anafilaxia/terapia , Animais , Venenos de Abelha/imunologia , Criação de Abelhas/estatística & dados numéricos , Epinefrina/administração & dosagem , Família , Feminino , Humanos , Mordeduras e Picadas de Insetos/tratamento farmacológico , Mordeduras e Picadas de Insetos/imunologia , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/imunologia , Restaurantes/estatística & dados numéricos , Fatores de Risco , Inquéritos e Questionários/estatística & dados numéricos , Turquia
18.
BMC Infect Dis ; 20(1): 223, 2020 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-32171281

RESUMO

BACKGROUND: Streptococcus suis is a zoonotic pathogen that causes serious systemic infections in pigs and occupation-related infections in humans who contact with pigs or pork products. In China, it has caused two outbreaks of human infection and surveillance for S.suis has been ongoing since last time. CASE PRESENTATION: Two cases of meningitis and sepsis caused by S. suis were reported in this study. Both patients work in relation to the pork trade, a risk factor for S. suis infection. The outcome was favorable after a prolonged ceftriaxone therapy but one patient was left with mild hearing loss. Two isolates were identified as sequencing type (ST) 7, S. suis serotype 2 (SS2), which is one the most prevalent and cause two outbreaks in China. Whole-genome sequencing (WGS) revealed that a high degree identity was noted in the genome organizations and sequences between two sporadic ST7 SS2 isolates in this study and representative epidemic virulent isolates. Major differences among them are two sporadic ST7 SS2 isolates lacked a virulence factor called agglutinin receptor and an 89 K pathogenicity island (PAI), which plays important role in the pathogenesis of streptococcal toxic shock syndrome (STSS). A summary about STs of human infection with S. suis in China was completed. The result showed ST1 and ST7 were still the major STs and several novel STs were successfully discovered in different provinces. CONCLUSIONS: Our results enhanced the understanding of the ability to cause life-threatening infections in humans and the distribution and evolution of the S. suis in China.


Assuntos
Epidemias , Doenças Profissionais/microbiologia , Sorogrupo , Infecções Estreptocócicas/epidemiologia , Infecções Estreptocócicas/genética , Streptococcus suis/genética , Doenças dos Suínos/epidemiologia , Idoso , Animais , Antibacterianos/uso terapêutico , Ceftriaxona/uso terapêutico , China/epidemiologia , Genoma Bacteriano/genética , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/tratamento farmacológico , Choque Séptico/tratamento farmacológico , Choque Séptico/microbiologia , Infecções Estreptocócicas/tratamento farmacológico , Infecções Estreptocócicas/microbiologia , Streptococcus suis/isolamento & purificação , Suínos/microbiologia , Doenças dos Suínos/transmissão , Resultado do Tratamento , Fatores de Virulência
19.
Med Care ; 58(3): 241-247, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32106166

RESUMO

BACKGROUND: Prescription opioid overdose has increased markedly and is of great concern among injured workers receiving workers' compensation insurance. Given the association between high daily dose of prescription opioids and negative health outcomes, state workers' compensation boards have disseminated Morphine Equivalent Daily Dose (MEDD) guidelines to discourage high-dose opioid prescribing. OBJECTIVE: To evaluate the impact of MEDD guidelines among workers' compensation claimants on prescribed opioid dose. METHODS: Workers' compensation claims data, 2010-2013 from 2 guideline states and 3 control states were utilized. The study design was an interrupted time series with comparison states and average monthly MEDD was the primary outcome. Policy variables were specified to allow for both instantaneous and gradual effects and additional stratified analyses examined evaluated the policies separately for individuals with and without acute pain, cancer, and high-dose baseline use to determine whether policies were being targeted as intended. RESULTS: After adjusting for covariates, state fixed-effects, and time trends, policy implementation was associated with a 9.26 mg decrease in MEDD (95% confidence interval, -13.96 to -4.56). Decreases in MEDD also became more pronounced over time and were larger in groups targeted by the policies. CONCLUSIONS: Passage of workers' compensation MEDD guidelines was associated with decreases in prescribed opioid dose among injured workers. Disseminating MEDD guidelines to doctors who treat workers' compensation cases may address an important risk factor for opioid-related mortality, while still allowing for autonomy in practice. Further research is needed to determine whether MEDD policies influence prescribing behavior and patient outcomes in other populations.


Assuntos
Analgésicos Opioides/administração & dosagem , Prescrições de Medicamentos , Morfina/administração & dosagem , Doenças Profissionais/tratamento farmacológico , Guias de Prática Clínica como Assunto , Indenização aos Trabalhadores , Adulto , Dor Crônica/tratamento farmacológico , Prescrições de Medicamentos/normas , Prescrições de Medicamentos/estatística & dados numéricos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Padrões de Prática Médica
20.
J Acoust Soc Am ; 146(5): 3906, 2019 11.
Artigo em Inglês | MEDLINE | ID: mdl-31795710

RESUMO

Music industry professionals represent a vulnerable population to music induced hearing disorders (MIHDs). In addition to the impacts that the development of hearing disorders secondary to noise exposure can have on quality of life and communication, MIHDs can impact the afflicted individual's professional performance, and in turn employability. Within the music industry there are individual and institutional barriers to traditional hearing conservation interventions. Pharmaceutical interventions for hearing loss could potentially address some of these barriers, yet there are significant considerations and cautions which should be addressed.


Assuntos
Perda Auditiva Provocada por Ruído/epidemiologia , Música , Doenças Profissionais/epidemiologia , Perda Auditiva Provocada por Ruído/tratamento farmacológico , Perda Auditiva Provocada por Ruído/fisiopatologia , Humanos , Ruído Ocupacional/efeitos adversos , Doenças Profissionais/tratamento farmacológico , Doenças Profissionais/fisiopatologia , Exposição Ocupacional/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...